EDITORIAL

New Publisher for the Journal of Clinical Oncology

JCO Dec 1 1998: 3719. [PDF]

ARTICLES
	Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial
	H Joensuu, K Holli, M Heikkinen, E Suonio, AR Aro, P Hietanen, and R Huovinen
	JCO Dec 1 1998: 3720–3730. [Abstract] [PDF]
	Inflammatory breast cancer and body mass index
	S Chang, AU Buzdar, and SD Hursting
	JCO Dec 1 1998: 3731–3735. [Abstract] [PDF]
	Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients
	K Fizazi, N Dohollou, JY Blay, S Guerin, A Le Cesne, F Andre, P Pouillart, T Tursz, and BB Nguyen
	JCO Dec 1 1998: 3736–3743. [Abstract] [PDF]
	Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group
	DM Green, NE Breslow, JB Beckwith, JZ Finklestein, P Grundy, PR Thomas, T Kim, S Shochat, G Haase, M Ritchey, P Kelalis, and GJ D'Angio
	JCO Dec 1 1998: 3744–3751. [Abstract] [PDF]
	Bone mass after treatment for acute lymphoblastic leukemia in childhood
	K Nysom, K Holm, KF Michaelsen, H Hertz, J Muller, and C Molgaard
	JCO Dec 1 1998: 3752–3760. [Abstract] [PDF]
	Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital
	AW Walter, ML Hancock, CH Pui, MM Hudson, JS Ochs, GK Rivera, CB Pratt, JM Boyett, and LE Kun
	JCO Dec 1 1998: 3761–3767. [Abstract] [PDF]
	Reappraisal of the clinical and biologic significance of myeloid- associated antigen expression in childhood acute lymphoblastic leukemia
	CH Pui, JE Rubnitz, ML Hancock, JR Downing, SC Raimondi, GK Rivera, JT Sandlund, RC Ribeiro, DR Head, MV Relling, WE Evans, and FG Behm
	JCO Dec 1 1998: 3768–3773. [Abstract] [PDF]
	Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia
	J Ciudad, JF San Miguel, MC Lopez-Berges, B Vidriales, B Valverde, M Ocqueteau, G Mateos, MD Caballero, J Hernandez, MJ Moro, MV Mateos, and A Orfao
	JCO Dec 1 1998: 3774–3781. [Abstract] [PDF]
	Determinants of prognosis in late chronic-phase chronic myelogenous leukemia
	J Rodriguez, J Cortes, T Smith, S O'Brien, MB Rios, M Talpaz, and H Kantarjian
	JCO Dec 1 1998: 3782–3787. [Abstract] [PDF]
	Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group
	F Davi, HJ Delecluse, P Guiet, J Gabarre, A Fayon, O Gentilhomme, P Felman, C Bayle, F Berger, J Audouin, PA Bryon, J Diebold, and M Raphael
	JCO Dec 1 1998: 3788–3795. [Abstract] [PDF]
	Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients
	SL Goldberg, TR Klumpp, AJ Magdalinski, and KF Mangan
	JCO Dec 1 1998: 3796–3802. [Abstract] [PDF]
	Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma
	IF Khouri, J Romaguera, H Kantarjian, JL Palmer, WC Pugh, M Korbling, F Hagemeister, B Samuels, A Rodriguez, S Giralt, A Younes, D Przepiorka, D Claxton, F Cabanillas, and R Champlin
	JCO Dec 1 1998: 3803–3809. [Abstract] [PDF]
	BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group
	V Diehl, J Franklin, D Hasenclever, H Tesch, M Pfreundschuh, B Lathan, U Paulus, M Sieber, JU Rueffer, M Sextro, A Engert, J Wolf, R Hermann, L Holmer, U Stappert-Jahn, E Winnerlein-Trump, G Wulf, S Krause, A Glunz, K von Kalle, H Bischoff, C Haedicke, E Duehmke, A Georgii, and M Loeffler
	JCO Dec 1 1998: 3810–3821. [Abstract] [PDF]
	Ongoing somatic mutations and clonal expansions after cure of Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue B-cell lymphoma [published erratum appears in J Clin Oncol 1999 Mar;17(3):1092]
	C Thiede, B Alpen, A Morgner, M Schmidt, M Ritter, G Ehninger, M Stolte, E Bayerdorffer, and A Neubauer
	JCO Dec 1 1998: 3822–3831. [Abstract] [PDF]
	Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group
	JCO Dec 1 1998: 3832–3842. [Abstract] [PDF]
	Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma
	PW Pisters, JL Abbruzzese, NA Janjan, KR Cleary, C Charnsangavej, MS Goswitz, TA Rich, I Raijman, RA Wolff, R Lenzi, JE Lee, and DB Evans
	JCO Dec 1 1998: 3843–3850. [Abstract] [PDF]
	DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma
	HS Friedman, RE McLendon, T Kerby, M Dugan, SH Bigner, AJ Henry, DM Ashley, J Krischer, S Lovell, K Rasheed, F Marchev, AJ Seman, I Cokgor, J Rich, E Stewart, OM Colvin, JM Provenzale, DD Bigner, MM Haglund, AH Friedman, and PL Modrich
	JCO Dec 1 1998: 3851–3857. [Abstract] [PDF]
	Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors
	LB Saltz, D Spriggs, LJ Schaaf, GK Schwartz, D Ilson, N Kemeny, J Kanowitz, C Steger, M Eng, P Albanese, D Semple, CK Hanover, GL Elfring, LL Miller, and D Kelsen
	JCO Dec 1 1998: 3858–3865. [Abstract] [PDF]
	Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignancies
	CH Spiridonidis, LR Laufman, J Jones, VA Rhodes, K Wallace, and S Nicol
	JCO Dec 1 1998: 3866–3873. [Abstract] [PDF]
	Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison
	GC Toner, JD Shapiro, CR Laidlaw, D Rischin, MJ Millward, M Wolf, H Januszewicz, SV Mitchell, AC Curran, JP Matthews, and JF Bishop
	JCO Dec 1 1998: 3874–3879. [Abstract] [PDF]
	Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review
	BH Kushner, NK Cheung, K Kramer, G Heller, and SC Jhanwar
	JCO Dec 1 1998: 3880–3889. [Abstract] [PDF]
	Current use of bisphosphonates in oncology. International Bone and Cancer Study Group
	JJ Body, R Bartl, P Burckhardt, PD Delmas, IJ Diel, H Fleisch, JA Kanis, RA Kyle, GR Mundy, AH Paterson, and RD Rubens
	JCO Dec 1 1998: 3890–3899. [Abstract] [PDF]
	Economic issues in lung cancer: a review
	PJ Goodwin and FA Shepherd
	JCO Dec 1 1998: 3900–3912. [Abstract] [PDF]
Primary cardiac angiosarcoma presenting as a malignant pericardial effusion
C Wu, M Vasconcelles, P DePiro, A Van den Abbeele, A Rakusin, K Bechard, and A Skarin
JCO Dec 1 1998: 3913–3915. [PDF]
CD20-negative relapse in B-cell lymphoma after treatment with Rituximab
T Kinoshita, H Nagai, T Murate, and H Saito
JCO Dec 1 1998: 3916a. [PDF]
Adjuvant chemotherapy with CEF versus CMF for node-positive breast cancer
CD Atkins
JCO Dec 1 1998: 3916b–3917. [PDF]
Concurrent G-CSF and chemotherapy
RB Livingston
JCO Dec 1 1998: 3917. [PDF]
Second cancer after acute lymphoblastic leukemia
DM Green
JCO Dec 1 1998: 3918a. [PDF]
Elective internal mammary node irradiation: it is not an all or nothing question
LB Marks and LR Prosnitz
JCO Dec 1 1998: 3918b. [PDF]
Glutamine treatment of paclitaxel-induced myalgias and arthralgias
D Savarese, J Boucher, and B Corey
JCO Dec 1 1998: 3918c–3919. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.